ROMNEY RONNA 4

What Happened
Ronna Romney, a director of Molina Healthcare, sold 506 shares in an open-market sale on March 12, 2026. The reported volume-weighted average price (VWAP) was $146.92, resulting in proceeds of approximately $74,342. This was a sale (disposition) rather than a purchase or grant; sales by insiders are often routine and do not necessarily signal a change in view of the company.

Key Details

• Transaction date: 2026-03-12; Form filed: 2026-03-13 (timely filing).
• Transaction type/code: Sale (S) — open-market or private sale.
• Shares sold: 506; VWAP reported $146.92; total proceeds ≈ $74,342. Reported actual trade prices ranged $146.80–$147.10 (footnote F1).
• Post-transaction holdings: The filing notes that all shares are held by the Ronna Romney Revocable Trust (footnote F2). The specific post-sale share count was not provided in the summary.
• Footnotes: F1 explains the reported price is a VWAP within a $1 range and that the filer can provide per-price quantities on request; F2 states shares are held by the Revocable Trust.
• Filing timeliness: Not indicated as late.

Context: This report documents a straightforward sale of existing shares held in a trust. Sales are common for reasons like portfolio rebalancing or tax planning; they are less informative about insider sentiment than purchases. No options were exercised and no awards or gifts are involved in this transaction.